Drugs / MADALENA ASSOCIATION
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04670666 | Nov 2024 → Jul 2026 overdue | type 2 diabetes mellitus | EMS | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MADALENA ASSOCIATION | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04670666 ↗ |
| Route | Oral | “1 tablet Madalena association, oral;” NCT04670666 ↗ |